Abbott Laboratories (ABT)

ABT (NYSE:Health Services)
$37.97
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | ABT Avg Daily Volume: 8,827,100
Last Update: 04/15/14 - 4:00 PM EDT
Volume: 0
YTD Performance: -0.94%
Open: $0.00
Previous Close: $37.97
52 Week Range: $32.70 - $40.49
Oustanding Shares: 1,543,070,300
Market Cap: 58,235,473,122
6-Month Chart
TheStreet Ratings Grade for ABT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 8 8
Moderate Buy 2 2 2 1
Hold 7 7 7 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.91 1.91 1.91 2.00
Latest Dividend: 0.22
Latest Dividend Yield: 2.22%
Dividend Ex-Date: 04/11/14
Price Earnings Ratio: 26.49
Price Earnings Comparisons:
ABT Sector Avg. S&P 500
26.49 23.30 28.47
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-3.95% 5.09% 46.32%
GROWTH 12 Mo 3 Yr CAGR
Revenue -45.20 -0.38 -0.15
Net Income -56.80 -0.48 -0.20
EPS -56.80 -0.45 -0.18
Earnings for ABT:
EBITDA 4.35B
Revenue 21.85B
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $0.35 $0.51 $2.20 $2.49
Number of Analysts 14 12 18 16
High Estimate $0.36 $0.51 $2.29 $2.78
Low Estimate $0.34 $0.49 $2.17 $2.42
Prior Year $0.42 $0.46 $2.01 $2.20
Growth Rate (Year over Year) -15.99% 9.78% 9.51% 12.95%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bullish
Mar 19, 2014 | 7:29 AM EDT
ABT lowered its number, Jefferies said. Pricing pressure in EPD, MD pricing/volume pressurse and FX exposure. $45 price target. Buy rat...
Update
Feb 12, 2014 | 8:02 AM EST
Shares of ABT dropped to $46, according to Jefferies. Pricing pressure in EPS and FX exposure. Buy rating. 
Great investors and great quarterbacks have a lot in common.

Healthcare Holding Strong Real Money Pro($)

It's clear that bulls in this sector aren't weak hands.

Abbott Labs Breaks Out Real Money Pro($)

Bullish action has set the stock up well for more upside.
U.S. futures are positive to start first full week of 2014 trading.
Bullish
Jan 06, 2014 | 8:20 AM EST
ABT was upgraded to Overweight, Morgan Stanley said. $45 price target. Company is cutting costs and earnings growth can reaccelerate.&n...
Update: Let's look at the big hits, not just the misses.
This season isn't the drag it's made out to be.
UPDATE: Futures higher as Senate negotiations restart.

Columnist Conversations

After the close Yahoo reported another pathetic quarter. Revenue rose 1.2% to $1.09 billion vs the $1.08 bin c...
Wow, have not seen an intraday rally like today's to the upside like this for quite some time. Encouraging we...
Today's probing low followed by a recovery signals to us that the seasonal pattern of April mid-month strength...
Traders couldn't ask for much bigger swings than we've been seeing over the past two sessions. It's been pret...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.